Pfizer Inc.
A maker of medicines and vaccines, Pfizer produces well-known drugs like the blood thinner Eliquis, the Prevnar pneumonia vaccines, the Covid shot Comirnaty, the antiviral Paxlovid, and cancer treatments Ibrance and Xtandi, used by patients around the world. It was founded in 1849 in Brooklyn by German cousins Charles Pfizer, a chemist, and Charles Erhart, a confectioner, who began by coating a bitter worm medicine in almond-flavored toffee candy. Its most famous discovery, the erectile-dysfunction drug Viagra, was a happy accident—originally developed as a heart medication for angina.
Granted 1.44M
Granted 461.4K
Granted 212.6K
Granted 112.0K
Granted 29.4K
Granted 100.2K
Granted 74.4K
Granted 109.9K
Granted 129.5K
Bought 19.5K
Granted 82.1K · Sold 9.7K
Bought 4.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bourla AlbertChairman & CEO, Director · 12 transactions | +26% | 394.7K | 1.44M | — | — |
| Dolsten MikaelPresident R&D · 2 transactions | -9.1% | 323.7Kas of Feb 2024 | — | — | — |
| Lankler Douglas MExecutive Vice President · 12 transactions | +107.7% | 284.3K | 461.4K | — | — |
| Susman SallyExecutive Vice President · 9 transactions | -19.1% | 169.8Kas of Mar 2025 | 212.6K | — | — |
| Boshoff ChristoffelPresident, R&D · 21 transactions | — | 168.9K | 112.0K | — | — |
| Johnson Rady AExecutive Vice President · 3 transactions | +3.9% | 127.2Kas of Feb 2024 | 29.4K | — | — |
| Sahni PayalExecutive Vice President · 12 transactions | +191.3% | 97.4K | 100.2K | — | — |
| de Germay AlexandreExecutive Vice President · 1 transaction | — | 74.4Kas of Feb 2024 | 74.4K | — | — |
| McDermott MichaelExecutive Vice President · 16 transactions | -8.1% | 74.3K | 109.9K | — | — |
| Fonseca LidiaExecutive Vice President · 6 transactions | +29.9% | 46.5K | 129.5K | — | — |
| Denton David MChief Financial Officer & EVP · 1 transaction | -21.4% | 37.9Kas of May 2024 | — | — | — |
| Blaylock Ronald EDirector · 1 transaction | — | 32.5Kas of Feb 2025 | — | 19.5K | — |
| Damico Jennifer B.SVP & Controller · 24 transactions | +248.7% | 31.4K | 82.1K | — | 9.7K |
| Malik AamirExecutive Vice President · 1 transaction | -35.7% | 29.5Kas of Aug 2024 | — | — | — |
| Gottlieb ScottDirector · 2 transactions | +66.7% | 10.0Kas of Oct 2024 | — | 4.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +13.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.